obesity drug news today glp-1 oct 27 2025 More news: in a late-stage study in type 2 diabetes and elevated cardiovascular risk, our new GLP-1 pill showed cardiovascular safety. Read more: https://e.lilly/4myJlm8 Obesity GLP-1 Market
Description
Learn how and why GLP-1 medications work
Serena Williams says she has lost weight using GLP-1 medication
Ascletis ASC35, a once-monthly GLP-1/GIP peptide using a self-assembling lipid depot, cleared FDA IND for Phase 1 head-to-head vs weekly tirzepatide June 23.
This article looks at the unwanted side effects of glucagon-like peptide-1 (GLP-1) receptor agonists
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach
Summary GLP-1 RAs alter gastrointestinal motility at all levels of the GI tract, with delayed gastric emptying being the most well characterized
